Medigen Vaccine Biologics Corporation (TPEX: 6547)

Medigen Vaccine Biologics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,052	1,393	1,204	1,380	1,679	410.62
Short-Term Investments	724.5	2,364	2,980	800	-	-
Trading Asset Securities	-	-	52.99	53.1	53.17	53.23
Cash & Short-Term Investments	1,776	3,757	4,237	2,233	1,733	463.85
Cash Growth	-53.94%	-11.33%	89.77%	28.87%	273.52%	-35.54%
Accounts Receivable	189.35	149.11	194.4	640.19	4.46	-
Other Receivables	7.53	49.74	1.17	0.07	126.25	-
Receivables	196.88	198.84	195.57	640.26	130.72	-
Inventory	473.36	386.47	903.4	610.84	77.43	8.4
Prepaid Expenses	19.23	10.66	12.37	32.29	17.3	2.9
Other Current Assets	51.74	48.14	113.89	205.07	51.64	43.79
Total Current Assets	2,517	4,401	5,462	3,721	2,010	518.93
Property, Plant & Equipment	1,343	1,385	1,470	1,414	1,343	1,663
Long-Term Investments	396.1	246.13	263.56	54	-	-
Other Intangible Assets	33.43	38.3	45.36	52.98	60.01	61.81
Other Long-Term Assets	16.76	22.36	106.83	57.26	77.71	33.28
Total Assets	4,307	6,093	7,348	5,299	3,491	2,277
Accounts Payable	15.79	25.89	109.1	88.53	21.78	34.32
Short-Term Debt	-	-	-	-	-	30
Current Portion of Long-Term Debt	22.95	1,708	-	-	-	77.08
Current Portion of Leases	12.09	12	11.78	1.99	1.93	8.36
Current Unearned Revenue	-	-	-	111.41	-	-
Other Current Liabilities	159.2	245.73	234.35	237.15	137.27	78.07
Total Current Liabilities	210.02	1,992	355.23	439.09	160.98	227.83
Long-Term Debt	-	-	1,678	-	-	356.09
Long-Term Leases	250.52	254.36	266.35	183.87	185.85	326.37
Other Long-Term Liabilities	-	-	19.25	-	2.58	-
Total Liabilities	460.55	2,246	2,319	622.95	349.4	910.28
Common Stock	3,287	3,286	3,278	2,129	2,111	1,560
Additional Paid-In Capital	395.01	1,551	2,798	1,135	2,319	294.58
Retained Earnings	81.63	-1,018	-1,132	1,410	-1,292	-617.72
Comprensive Income & Other	82.79	27.85	84.03	1.92	3.27	129.67
Shareholders' Equity	3,846	3,847	5,029	4,676	3,141	1,367
Total Liabilities & Equity	4,307	6,093	7,348	5,299	3,491	2,277
Total Debt	285.56	1,974	1,956	185.85	187.78	797.89
Net Cash (Debt)	1,491	1,783	2,281	2,047	1,545	-334.04
Net Cash Growth	-21.20%	-21.85%	11.45%	32.50%	-	-
Net Cash Per Share	4.54	5.43	7.05	6.37	5.57	-1.45
Filing Date Shares Outstanding	328.65	328.61	327.84	315.67	313.02	231.36
Total Common Shares Outstanding	328.65	328.61	327.84	315.67	313.02	231.36
Working Capital	2,307	2,410	5,107	3,282	1,849	291.1
Book Value Per Share	11.70	11.71	15.34	14.81	10.04	5.91
Tangible Book Value	3,813	3,808	4,984	4,623	3,081	1,305
Tangible Book Value Per Share	11.60	11.59	15.20	14.65	9.84	5.64
Buildings	1,131	1,130	1,127	1,121	1,117	1,117
Machinery	686.07	650.64	626.59	570.9	388.46	383.4
Construction In Progress	2.64	21.37	14.54	4.7	17.54	100
Leasehold Improvements	3.27	3.34	3.03	2.55	1.89	1.89

Source: S&P Capital IQ. Standard template. Financial Sources.